Apellis Pharmaceuticals (APLS) PT Raised to $41 at Mizuho

April 1, 2026 9:38 AM

Mizuho analyst Graig Suvannavejh raised the price target on Apellis Pharmaceuticals (NASDAQ: APLS) to $41.00 (from $20.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found